Analyst Insights

A Glimpse into Hewlett Packard Enterprise (HPE) Challenges

As HPE’s competition has odds to just get more fierce, Susquehanna Mehdi Hosseini shares his takeaways from the tech giant’s FQ2:18 show from the sidelines.

Should Tesla (TSLA) Investors Be Nervous as Consumer Reports Just Bashed the Model 3?

Considering Consumer Reports has a history of not grasping just how “groundbreaking” a mass market product can be, Gene Munster defends Tesla’s potential here. (CTRP) Draws Price Target Lift from Oppenheimer Following Ramping Market Share Gains

Oppenheimer’s Jed Kelly now anticipates 16% in return potential from on back of a strong Q1 earnings show.

RBC Capital Bumps Up Price Target on Square (SQ) Stock; Here’s Why

With valuation potential that has RBC Capital’s Daniel Perlin encouraged, the analyst now angles for 19% in return potential for SQ shares.

Could Tesla (TSLA) Stock Make the Big Jump to $500? This Analyst Gets More Confident

Anticipating stellar profitability from Tesla on its mass market Model 3, Berenberg’s Alexander Haissl now angles for the tech giant to hit $500 in stock price.

General Electric (GE): How Do You Solve a Problem Like Bleeding Capital?

J.P. Morgan’s Stephen Tusa warns to expect high probability on one more GE dividend cut for a company desperate for more capital.

Micron (MU): A Fascinating Story of Growth, Execution, and Attractive Valuation

On back of Micron’s 2018 Analyst Conference, Nomura’s Romit Shah has come away with strong confidence in the chip giant’s potential in the industry.

Dycom’s (DY) Post-Earnings Weakness Creates Attractive Entry Point, Says Canaccord

Shares of Dycom (NYSE:DY) got devastated after earnings today. For the first fiscal quarter, analysts …

Micron (MU) Wins a Big Vote of Confidence from Wall Street Firms; Highest Price Target Reaches $115

Following Micron’s (NASDAQ:MU) upbeat and well-attended analyst day and positive pre-announcement, the chip giant received at …

Sesen Bio (SESN) Draws Price Target Lift from H.C. Wainwright Following Strong Initial Pivotal Trial Results

H.C. Wainwright’s Swayampakula Ramakanth now bets on 54% in return potential for SESN stock on the heels of encouraging 3-month data in NMIBC.